Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.42%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
0.39 Up 0.00(0.15%) May 22, 3:57PM EDT
Add to Portfolio
Prev Close:0.39
Open:0.39
Bid:N/A
Ask:0.48 x 100
1y Target Est:4.00
Beta:2.49
Earnings Date:Aug 12 - Aug 17 (Est.)
Day's Range:0.39 - 0.41
52wk Range:0.33 - 1.75
Volume:524,984
Avg Vol (3m):558,488
Market Cap:11.01M
P/E (ttm):N/A
EPS (ttm):-0.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OPXAUp 0.15%11.01M
SNYDown 1.01%132.66B
TEVADown 0.60%51.77B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.64
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.51
Quarterly EPS Est (Jun-15) :-0.13
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases, such as neuromyelitis optica (NMO) based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback